GOLGA8Q: A Potential Drug Target and Biomarker for GPCR-Caused Diseases

Target Name: GOLGA8Q

NCBI ID: G727909

GOLGA8Q

Other Name(s): GOG8Q_HUMAN | Golgin A8 family member Q | Golgin subfamily A member 8Q | golgin A8 family member Q

GOLGA8Q: A Potential Drug Target and Biomarker for GPCR-Caused Diseases

GOLGA8Q (GOG8Q_HUMAN), also known as GOLGAsite8q, is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and muscle. It is a member of the GOLGAsite family, which includes proteins that are involved in the intracellular signaling pathway known as the G-protein-coupled receptor (GPCR) signaling pathway.

GOLGA8Q is a 21-kDa protein that is expressed in the brain, heart, liver, and muscle. It is localized to the endoplasmic reticulum (ER) and the transmembrane space (TMS). GOLGA8Q is a scaffold protein that is involved in the formation of the endoplasmic reticulum and the transmembrane space. It helps to regulate the trafficking of proteins to and from the ER and TMS.

GOLGA8Q is also involved in the regulation of the cytoskeleton. It helps to maintain the integrity of the cytoskeleton by interacting with microtubules and the actin filaments. This interaction between GOLGA8Q and the cytoskeleton is important for the proper functioning of the cell and for the development and maintenance of various diseases, such as cancer.

GOLGA8Q is a potential drug target for various diseases. Its involvement in the intracellular signaling pathway known as the GPCR signaling pathway makes it a promising target for diseases that are caused by the over-expression or dysfunction of GPCR signaling pathway. For example, GOLGA8Q has been shown to be involved in the regulation of the growth and differentiation of cancer cells. It has also been shown to play a role in the regulation of inflammation and fibrosis.

In addition to its potential as a drug target, GOLGA8Q is also a biomarker for various diseases. Its involvement in the regulation of the intracellular signaling pathway known as the GPCR signaling pathway makes it a potential target for diseases that are caused by the over-expression or dysfunction of GPCR signaling pathway. For example, GOLGA8Q has been shown to be involved in the regulation of the growth and differentiation of cancer cells, which makes it a potential biomarker for cancer.

GOLGA8Q is also a potential target for diseases caused by the dysfunction of the cytoskeleton. Its interaction with the cytoskeleton is important for the proper functioning of the cell, and disorders that affect the cytoskeleton, such as osteoporosis, have been linked to the dysfunction of GOLGA8Q.

In conclusion, GOLGA8Q is a protein that is expressed in various tissues of the human body and is involved in the intracellular signaling pathway known as the GPCR signaling pathway. It is a potential drug target for various diseases and a biomarker for the dysfunction of the cytoskeleton. Further research is needed to fully understand the role of GOLGA8Q in the regulation of cellular processes and to develop effective treatments for diseases caused by its dysfunction.

Protein Name: Golgin A8 Family Member Q

The "GOLGA8Q Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA8Q comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets